Terms of Service

1. Acceptance of Terms

By accessing, browsing, registering for, or using https://theclinicallighthouse.com or any associated mobile or web application, newsletter, or service (collectively, the "Platform"), you ("User") acknowledge that you have read, understood, and irrevocably agree to be bound by these Terms of Service ("Terms") and our Privacy Policy, which is incorporated herein by reference.

If you do not agree to all of these Terms in their entirety, you are expressly prohibited from using the Platform and must cease access immediately. Using any part of the Platform after these Terms have been posted constitutes acceptance.

These Terms constitute a legally binding agreement between you and The Clinical Lighthouse ("Company," "we," "us," or "our"). Where a conflict exists between these Terms and any other document, these Terms shall prevail unless otherwise expressly stated.

2. Definitions

The following defined terms apply throughout these Terms:

• "Platform" means the website at https://theclinicallighthouse.com, including all content, features, tools, applications, and services.
• "Content" means all text, summaries, editorial commentary, data, graphics, and other materials published on the Platform.
• "User" means any individual who accesses or uses the Platform, whether registered or not.
• "Subscriber" means a User who has purchased and maintains an active paid subscription plan.
• "Free User" means a registered User who accesses the Platform without a paid subscription.
• "Visitor" means an unregistered individual who accesses publicly available portions of the Platform.
• "Intellectual Property Rights" means all patents, trademarks, trade secrets, copyrights, database rights, and other proprietary rights worldwide.
• "User Data" means any personal or non-personal information you provide to or that we collect from you in connection with your use of the Platform.

3. Description of Service

The Clinical Lighthouse is a digital medical news platform that transforms newly published scientific and clinical research into concise editorial summaries for healthcare professionals. Content is produced through a hybrid process combining AI-assisted drafting and human editorial review by qualified clinicians. Our editorial workflow is described further in Section 10.

The Platform provides the following access tiers:

• Free tier: a curated selection of clinical news summaries available to registered users at no charge.
• Premium subscription: full content library, advanced features, priority access to new publications, and personalized reading experience, available upon payment of applicable fees.

The Clinical Lighthouse reserves the right, in its sole discretion and at any time without prior notice, to: modify, expand, or discontinue any feature or tier of the Platform; change the content available under each tier; or temporarily suspend the Platform for maintenance, upgrades, or security measures. The Company shall not be liable to any User for any consequence of such actions.

4. Eligibility and Access Restrictions

The Platform is intended exclusively for:

• Licensed healthcare professionals, including physicians, surgeons, nurses, pharmacists, dentists, physiotherapists, and allied health professionals holding a valid professional registration.
• Medical residents, interns, fellows, and postgraduate trainees enrolled in formally recognized training programs.
• Medical students and health sciences students enrolled in accredited academic institutions.

By accessing the Platform, you represent, warrant, and covenant that: (a) you meet at least one of the above eligibility criteria; (b) you are at least 18 years of age; (c) you are not barred from using the Platform under any applicable law; and (d) all information you provide is accurate and current.

We reserve the right to verify your professional credentials at any time and to suspend or terminate your account pending or following such verification. Providing false eligibility information is a material breach of these Terms.

The Platform is not intended for use by patients, caregivers, or members of the general public. The Clinical Lighthouse expressly disclaims any duty of care to non-professional users who access the Platform in breach of these eligibility requirements.

5. User Accounts

To access features beyond freely available public content, registration is required. By creating an account, you agree to:

• Provide accurate, current, complete, and non-misleading registration information.
• Maintain and promptly update your account details as circumstances change.
• Keep your login credentials strictly confidential and not share them with any third party under any circumstances.
• Accept sole and full responsibility for all activity that occurs under your account, whether or not authorized by you.
• Notify us immediately at sac@beyond78.com upon becoming aware of any unauthorized access to, or use or compromise of, your account or credentials.

The Clinical Lighthouse reserves the right to refuse registration to any applicant and to suspend or permanently terminate any account, with or without notice, for any reason including: breach of these Terms, provision of false or misleading information, fraudulent activity, abuse or disruption of the Platform, or conduct harmful to other users or to the Company's reputation. Account termination does not entitle the User to any refund except as expressly provided in Section 6.

You may only maintain one active account. Creating multiple accounts to circumvent access restrictions or bans is a material breach of these Terms.

6. Subscriptions, Billing, and Payments

6.1 Subscription Plans and Fees

Subscription plans, features, and pricing are as described on the Platform at the time of purchase. All fees are stated in the currency displayed at checkout. Fees are exclusive of applicable taxes (including ISS, PIS, COFINS, and VAT where applicable) unless expressly stated otherwise. You are responsible for all applicable taxes arising from your subscription.

6.2 Billing Authorization

By subscribing, you authorize the Company and its payment processors to charge your designated payment method for the full subscription fee at the start of each billing cycle. If a payment fails, we may retry the charge, and your access may be suspended until payment is received. You are responsible for maintaining a valid payment method on file.

6.3 Auto-Renewal and Cancellation

All subscriptions renew automatically at the end of each billing cycle (monthly or annual, as selected) at the then-current rate, unless you cancel at least 24 hours before the renewal date. Cancellation takes effect at the end of the current paid period; you retain access until that date. No partial-period refunds are issued upon cancellation unless required by law.

6.4 Free Trials

If we offer a free trial, it will commence on the date you activate it and end on the date specified. You may be required to provide payment details to activate a free trial. Unless you cancel before the trial ends, your subscription will automatically convert to a paid plan and you will be charged. Only one free trial per User.

6.5 Refund Policy

Under Brazilian consumer protection law (Código de Defesa do Consumidor — CDC, Law No. 8,078/1990, Art. 49), Users who contracted services remotely have an unconditional right to withdraw within 7 (seven) calendar days of the transaction date and receive a full refund. To exercise this right, contact us at sac@beyond78.com within 7 days of your purchase.

Outside the statutory 7-day window, subscription fees are non-refundable. Requests for exceptional refunds may be considered on a case-by-case basis at our sole discretion. Disputes regarding charges must be raised with us before initiating a chargeback with your payment provider; abusive chargebacks may result in account termination.

6.6 Price Changes

We may change subscription pricing at any time with at least 30 (thirty) days' prior notice by email and Platform notification. The new price takes effect at your next renewal. If you do not agree to the new price, you must cancel before the renewal date.

6.7 Payment Processing

Payments are processed by third-party processors. We do not store your full card number, CVV, or bank account details. You agree to comply with the applicable payment processor's terms of service.

Our summaries are derived from publicly available scientific abstracts and original editorial commentary. They are journalistic and educational in nature and do not represent comprehensive reviews of the underlying evidence. Key limitations include:

• Summaries may not capture methodological nuances, limitations, or conflicts of interest disclosed in full publications.
• Evidence may have been superseded, retracted, or re-evaluated after publication of our summary.
• Clinical applicability varies by jurisdiction, patient population, comorbidities, and institutional protocols.
• Regulatory approval status of drugs, devices, or interventions differs by country and may have changed.
• Inclusion of any study, trial, or finding on the Platform does not constitute endorsement, recommendation, or validation by the Company or its editorial team.

By using the Platform, you expressly and irrevocably acknowledge and agree that: (a) all clinical decisions remain solely within your professional judgment and responsibility; (b) you will independently verify Platform content against full primary sources, applicable clinical guidelines, and current regulatory information before any application to patient care; and (c) the Company expressly disclaims all liability for any clinical, therapeutic, diagnostic, or patient safety outcome arising from any reliance on Platform content.

8. Intellectual Property

8.1 Ownership

All original Content on the Platform — including editorial summaries, analytical commentary, visual design, user interface elements, brand assets, trademarks, trade dress, databases, and underlying technology — is the exclusive intellectual property of The Clinical Lighthouse and/or its licensors, protected under Brazilian Law No. 9,610/1998 (Lei de Direitos Autorais), Brazilian trademark law (Law No. 9,279/1996), and applicable international intellectual property conventions.

8.2 Limited User License

The Company grants you a limited, personal, non-exclusive, non-transferable, non-sublicensable, revocable license to access and use Platform Content solely for your own personal, non-commercial, and professional development purposes as a healthcare professional. This license expressly excludes any right to:

• Reproduce, copy, redistribute, publish, sell, license, or commercially exploit any Content.
• Create derivative works based on Platform Content.
• Systematically download, scrape, mirror, or extract Content through automated means.
• Remove, alter, or obscure any copyright, trademark, watermark, or attribution notice.
• Use Platform Content or data to train, evaluate, fine-tune, or improve any artificial intelligence, machine learning, or large language model system, without express prior written authorization.
• Frame, embed, or display the Platform within any other website, application, or service.
• Republish Content on social media or third-party platforms beyond brief excerpts with attribution.

8.3 Source Publication Rights

Our editorial summaries are independently authored based on publicly available abstracts and original analysis. We do not reproduce full-text articles from paywalled publications. All intellectual property in source scientific publications belongs exclusively to their respective authors, journals, and publishers, and our editorial output does not infringe upon those rights.

8.4 User Feedback

Any feedback, suggestions, or improvement ideas you provide to us are voluntary. By submitting feedback, you grant the Company a perpetual, irrevocable, worldwide, royalty-free, sublicensable license to use, adapt, and incorporate such feedback without any obligation of compensation, attribution, or notice.

8.5 Trademark Notice

"The Clinical Lighthouse" and associated logos and marks are trademarks or pending trademarks of the Company. You may not use these marks without prior written permission.

9. Prohibited Conduct

You agree that you will not, and will not attempt to:

• Use the Platform for any unlawful, fraudulent, or abusive purpose.
• Impersonate any person or entity, or misrepresent your professional qualifications or identity.
• Access, probe, test, or tamper with non-public areas of the Platform or its supporting infrastructure.
• Circumvent, disable, or interfere with security features or access controls.
• Share, sell, sublicense, or transfer your account credentials or subscription access.
• Use automated tools (bots, crawlers, scrapers) to access, monitor, or extract Platform Content without authorization.
• Introduce malware, viruses, or other harmful code into the Platform.
• Disrupt, overload, or impair the Platform's servers, infrastructure, or other users' experience.
• Harvest, collect, or compile personal data about other users.
• Post or transmit content that is defamatory, harassing, obscene, threatening, or that violates third-party rights.
• Use the Platform in any way that could damage the Company's reputation or undermine public trust in evidence-based medicine.

Violation of any prohibited conduct provision is a material breach of these Terms and may result in immediate account suspension or termination, pursuit of civil or criminal remedies, and claims for damages including legal fees and costs.

10. AI-Assisted Content and Editorial Standards

The Clinical Lighthouse uses AI tools to assist in the initial drafting of content summaries. Every AI-assisted draft is reviewed, fact-checked, and approved by a qualified clinician-editor prior to publication. Despite this review process, the Company does not warrant that Content is free from error, inaccuracy, omission, or outdated information.

AI assistance is a production tool only. It does not change the nature of Content as journalistic and educational output, nor does it reduce the User's professional obligation to independently verify all clinical information before application.

We reserve the right to update, correct, or retract Content at any time without prior notice. Where a material error is identified, we will publish a correction notice.

11. Beta Services and Platform Evolution

The Platform or certain features may be offered in a beta or early-access state at launch. Beta features are provided on an experimental basis and may be modified or discontinued without notice. They may contain bugs or errors not present in stable releases. Your use of beta features is at your own risk, and feedback you provide on beta features is subject to Section 8.4.

We may introduce new features, change existing features, or retire features as the Platform matures. We will endeavor to communicate significant changes in advance but reserve the right to make changes at our discretion.

12. Limitation of Liability

The Company's total aggregate liability for all claims arising under or related to these Terms, regardless of the form of action, shall not exceed the greater of: (a) the total fees paid by you to the Company in the 12 months immediately preceding the event giving rise to the claim; or (b) BRL 100.00 (one hundred Brazilian reais).

These limitations apply to the fullest extent permitted by applicable law. Some jurisdictions do not permit exclusion of certain damages; in those jurisdictions, the above limitations apply to the maximum extent permitted.

Nothing in these Terms limits liability for: death or personal injury caused by the Company's gross negligence or wilful misconduct; fraud or fraudulent misrepresentation; or any other liability that cannot be excluded under applicable mandatory law.

13. Disclaimer of Warranties

The Company does not warrant that errors will be corrected, that the Platform will be available at any particular time, or that servers are free of harmful components.

14. Indemnification

You agree to indemnify, defend, and hold harmless the Company and its officers, directors, employees, agents, affiliates, licensors, and service providers from and against any and all claims, actions, demands, liabilities, damages, awards, settlements, losses, costs, and expenses (including reasonable legal fees) arising out of or relating to:

• Your breach of any provision of these Terms.
• Your use of the Platform, including any clinical or patient care decisions made in reliance on Platform Content.
• Your infringement of any third-party right, including Intellectual Property Rights or privacy rights.
• Any content you submit, upload, or transmit through or in connection with the Platform.
• Your misrepresentation of your professional status, credentials, or identity.
• Any claim by a third party (including patients) arising from your use of Platform Content in a professional context.

15. Third-Party Links and Services

The Platform may contain links to third-party websites, journals, databases, or services. These links are provided for reference and convenience only. The Company does not control, endorse, or accept responsibility for third-party content, accuracy, privacy practices, or availability. Your use of third-party sites is at your own risk and subject to their own terms.

16. Force Majeure

The Company shall not be in breach of these Terms or liable for any failure or delay in performance to the extent caused by circumstances beyond its reasonable control, including: acts of God, natural disasters, epidemics or pandemics, war, terrorism, government actions or regulations, judicial orders, internet or telecommunications infrastructure failures, power outages, cyberattacks or data breaches by third parties, or industrial action.

17. Modifications to These Terms

We reserve the right to modify these Terms at any time. For material changes — those that affect your rights, obligations, or the nature of the services — we will notify you by email and post a prominent notice on the Platform at least 30 (thirty) days before the changes take effect. For non-material changes (such as clarifications, typographical corrections, or restructuring), we may update the Terms without specific notification.

Your continued use of the Platform after the effective date of any modification constitutes your acceptance of the modified Terms. If you do not accept the changes, you must cease using the Platform and, if applicable, cancel your subscription before the effective date.

18. Termination

These Terms are effective from the moment you first access the Platform and continue until terminated.

The Company may suspend or permanently terminate your access at any time, with or without prior notice, including if: you breach any provision of these Terms; you provide false eligibility or registration information; you engage in fraudulent, abusive, or harmful conduct; we are required to do so by law; or we determine your continued access poses a risk to the Platform, other users, or third parties.

You may terminate your account at any time by contacting us or using the account deletion feature (where available). Termination of your account does not extinguish obligations accrued prior to termination.

Upon termination for any reason: all licenses granted under these Terms immediately terminate; you must cease all use of the Platform; provisions that by their nature should survive (including Sections 7, 8, 12, 13, 14, 19, and 20) shall continue in full force.

19. Dispute Resolution and Governing Law

19.1 Good Faith Negotiation

Before initiating any formal legal or arbitration proceedings, both parties agree to attempt to resolve any dispute arising under or related to these Terms or the Platform through good-faith written negotiation for a minimum of 30 (thirty) calendar days after written notice of the dispute is sent to sac@beyond78.com. This obligation does not apply to urgent applications for injunctive relief.

19.2 Governing Law

These Terms are governed exclusively by the laws of the Federative Republic of Brazil, including the Código Civil (Law No. 10,406/2002), the Código de Defesa do Consumidor (Law No. 8,078/1990), the Marco Civil da Internet (Law No. 12,965/2014), and the Lei de Direitos Autorais (Law No. 9,610/1998). Conflict of law rules that would result in the application of another jurisdiction's law are expressly excluded.

19.3 Exclusive Jurisdiction

Any dispute not resolved through negotiation shall be submitted exclusively to the jurisdiction of the courts of the Comarca de Porto Alegre, Rio Grande do Sul, Brazil. Both parties irrevocably submit to the personal jurisdiction of those courts and waive any objection based on venue or inconvenient forum.

19.4 Class Action and Collective Proceedings Waiver

To the maximum extent permitted by applicable law, you agree that any claim or dispute arising under these Terms must be brought and resolved on an individual basis only, and not as part of any class, collective, coordinated, consolidated, or representative proceeding. This waiver does not apply to matters within the exclusive jurisdiction of the Brazilian consumer protection system (PROCON) or ANPD.

19.5 Consumer Rights Preservation

Nothing in this Section 19 limits or waives any rights you have as a consumer under the Código de Defesa do Consumidor, including the right to file complaints with PROCON or seek redress through Consumidor.gov.br.

20. General Provisions

• Entire Agreement: These Terms, together with the Privacy Policy and any additional terms applicable to specific features, constitute the entire and exclusive agreement between you and the Company regarding the Platform, superseding all prior agreements, representations, and understandings.
• Severability: If any provision is found invalid, illegal, or unenforceable, it shall be modified to the minimum extent necessary to make it valid and enforceable. All other provisions remain in full force.
• No Waiver: The Company's failure or delay in enforcing any right or provision does not constitute a waiver of that right or provision. Any waiver must be in writing and signed by an authorized representative.
• Assignment: You may not assign, delegate, or transfer any right or obligation under these Terms without our prior written consent. The Company may freely assign its rights and obligations, including in connection with a merger, acquisition, or sale of assets, without your consent.
• Notices: All legal notices to the Company must be sent in writing to sac@beyond78.com. Email notices are effective upon written acknowledgment of receipt.
• Relationship: Nothing in these Terms creates an employment, partnership, joint venture, agency, or franchise relationship between you and the Company.
• Language: These Terms are drawn up in English. If translated, the English version prevails in case of conflict.
• Electronic Contracting: You agree that these Terms, entered into electronically, satisfy any legal requirement for a written agreement and are fully enforceable.

21. Contact Information